Abstract:Endometrial carcinoma (EC) often exhibits resistance to hormone therapies, such as medroxyprogesterone acetate (MPA), highlighting the need for novel strategies to enhance therapeutic efficacy. The present study aimed to investigate the effects of polyphyllin VII (PPVII) on the efficacy of MPA in EC, focusing on the regulatory role of microRNA (miR)‐33a‐5p. Briefly, an MPA‐resistant Ishikawa cell line (Ishikawa/MPA‐R), maintained with 10 μM MPA, was established and transfected with negative control (NC) and miR‐33a‐5p inhibitors. Following treatment with PPVII and MPA, the proliferation capacity and apoptosis levels of the Ishikawa and Ishikawa/MPA‐R cells were evaluated using reverse transcription‐quantitative polymerase chain reaction, MTT assay, clonogenic assay, flow cytometry, western blotting and dual‐luciferase assay. Next, the expression levels of miR‐33a‐5p and F‐box and leucine rich repeat protein 16 (FBXL16) were measured, and the regulatory relationship between miR‐33a‐5p and FBXL16 was analyzed. Significant reductions in cell viability were observed in all groups following treatment with increased concentrations of MPA and PPVII, with the greatest effect observed in the combined MPA + PPVII group (P<0.01). The apoptosis levels of the Ishikawa/MPA‐R cells were significantly increased in all drug treatment groups, particularly in the MPA + PPVII group (P<0.05). PPVII treatment significantly increased the expression level of miR‐33a‐5p in Ishikawa/MPA‐R cells (P<0.01). In the PPVII + miR‐33a‐5p inhibitor group, the Ishikawa/MPA‐R cells exhibited an upregulation in the viability (P<0.01), colony formation ability (P<0.01), proportion in the G1 phase (P<0.05) and the protein expression levels of cyclin D1 (P<0.01) and cyclin‐dependent kinase 4 (P<0.01), and a reduction in the miR‐33a‐5p expression (P<0.01), apoptosis levels (P<0.05), proportion in the S (P<0.05) and G2 phases and the levels of Bcl‐2‐associated X protein (P<0.001). The FBXL16 protein expression in Ishikawa/MPA‐R cells was significantly higher compared with Ishikawa cells, and the mRNA and protein expression levels of FBXL16 were markedly elevated in the PPVII + miR‐33a‐5p inhibitor group compared with the PPVII + NC group (P<0.01). These findings suggested that PPVII upregulated the expression of miR‐33a‐5p, enhanced the sensitivity of EC cells to MPA and potentially exerted anticancer effects in EC through the synergistic action of the miR‐33a‐5p/FBXL16 axis in combination with MPA.

Asparanin A exerts cytotoxicity on human endometrial cancer Ishikawa cells via regulating miR-6236-p5_4 expression

Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway

Aspirin Inhibits Cancer Metastasis and Angiogenesis Via Targeting Heparanase

Multi-omics reveals the anticancer mechanism of asparagus saponin-asparanin A on endometrial cancer Ishikawa cells

Ellagitannin (BJA3121), an Anti‐proliferative Natural Polyphenol Compound, Can Regulate the Expression of MiRNAs in HepG2 Cancer Cells

Long Non-Coding RNA NNT-AS1 Positively Regulates NPM1 Expression to Affect the Proliferation of Estrogen-Mediated Endometrial Carcinoma by Interacting

Asiatic acid inhibits cervical cancer cell proliferation and migration via PI3K/AKT/mTOR signaling pathway

Role Of P38 Mapk In Enhanced Human Cancer Cells Killing By The Combination Of Aspirin And Abt-737

Erianin Suppresses Endometrial Cancer Progression by Regulating the miR-661/BOK Axis

Isorhamnetin Induces Apoptosis and Suppresses Metastasis of Human Endometrial Carcinoma Ishikawa Cells via Endoplasmic Reticulum Stress Promotion and Matrix Metalloproteinase-2/9 Inhibition In Vitro and In Vivo

Knockdown of Astrocyte Elevated Gene-1 Inhibits Tumor Growth and Modifies Micrornas Expression Profiles in Human Colorectal Cancer Cells.

Polyphyllin VII enhances the sensitivity of endometrial carcinoma cells to medroxyprogesterone acetate through upregulating miR‐33a‐5p expression

Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1

Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating miR-106b/PTEN/AKT/mTOR signaling pathway

The study of arsenic trioxide on the effect at medroxyprogesterone acetate resistant endometrial carcinoma cells

miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1

[MiR-217 Targeting PI3K/Akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid Leukemia]

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer

microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells

LncRNA RP11-395G23.3 Suppresses the Endometrial Cancer Progression Via Regulating Microrna-205-5p/pten Axis.